(19)
(11) EP 4 581 036 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23859254.7

(22) Date of filing: 25.08.2023
(51) International Patent Classification (IPC): 
C07D 498/22(2006.01)
A61P 35/00(2006.01)
A61K 31/4545(2006.01)
A61P 37/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 498/22; A61P 37/00; A61P 35/00; C07D 519/00; A61K 45/06
(86) International application number:
PCT/CN2023/114848
(87) International publication number:
WO 2024/046221 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 02.09.2022 WO PCT/CN2022/116914
13.07.2023 WO PCT/CN2023/107228

(71) Applicant: DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
Shanghai 201203 (CN)

(72) Inventors:
  • ZENG, Qingbei
    Shanghai 201203 (CN)
  • TSUI, Honchung
    Shanghai 201203 (CN)
  • YANG, Zhenfan
    Shanghai 201203 (CN)
  • ZHANG, Xiaolin
    Shanghai 201203 (CN)

(74) Representative: Simmons & Simmons LLP (Munich) 
Lehel Carré Gewürzmühlstraße 11
80538 Munich
80538 Munich (DE)

   


(54) EGFR INHIBITORS AND USES THEREOF